AU2002254717A1 - 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists - Google Patents

2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists

Info

Publication number
AU2002254717A1
AU2002254717A1 AU2002254717A AU2002254717A AU2002254717A1 AU 2002254717 A1 AU2002254717 A1 AU 2002254717A1 AU 2002254717 A AU2002254717 A AU 2002254717A AU 2002254717 A AU2002254717 A AU 2002254717A AU 2002254717 A1 AU2002254717 A1 AU 2002254717A1
Authority
AU
Australia
Prior art keywords
beta
derivatives useful
adrenoreceptor agonists
chroman derivatives
substituted chroman
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002254717A
Inventor
William H. Bullock
Ann-Marie Campbell
Miao Dai
Robert Dally
Jacques Dumas
Holia N. Hatoum-Mokdad
Uday Khire
Gaetan H. Ladouceur
Wendy Lee
Qingjie Liu
Derek B. Lowe
Steven R. Magnuson
Stephen J. O'connor
Ning Qi
Tatiana E. Shelekhin
Quanrong Shen
Roger A. Smith
Ming Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharmaceuticals Corp
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of AU2002254717A1 publication Critical patent/AU2002254717A1/en
Abandoned legal-status Critical Current

Links

AU2002254717A 2001-04-23 2002-04-22 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists Abandoned AU2002254717A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60/285,719 2001-04-23
US60/324,518 2001-09-26

Publications (1)

Publication Number Publication Date
AU2002254717A1 true AU2002254717A1 (en) 2002-11-05

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002341195A1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
AU2002312883A1 (en) Substituted cyclohexane-1,4-diamine derivatives
PL369567A1 (en) 1,6-naphthyridine derivatives as antidiabetics
AU2002253675A1 (en) Chromene compound
AU2002360733A1 (en) SUBSTITUTED 4,9-DIHYDROCYCLOPENTA(imn)PHENANTHRIDINE-5-ONES DERIVATIVES THEREOF AND THEIR USES
AUPR363301A0 (en) Dimeric isoflavones
AU2002228816A1 (en) Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
AU2002258529A1 (en) Antioxidant dermatological composition
AU2002357184A1 (en) SUBSTITUTED 6H-DIBENZO(c,h)CHROMENES AS ESTROGENIC AGENTS
AU2003269949A1 (en) Substituted 1,4-pyrazine derivatives
AU2002360752A1 (en) Viscoelastics for ocular surgery
AU2003258598A1 (en) Substituted 1,2,3,4-tetrahydroquinoline derivatives
AU2002254717A1 (en) 2,6-substituted chroman derivatives useful as beta-3 adrenoreceptor agonists
AU2003275360A1 (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
AU2002361027A1 (en) Substituted 1,5-diaminopentan-3-ol compounds
IL159965A0 (en) Novel 2,4-diaminothiazole derivatives
AU2003216904A1 (en) Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate
AU2002323693A1 (en) Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists
AU2002345403A1 (en) Novel 2,4-difluorobenzamide derivatives as antiviral agents
AU2002302448A1 (en) Formailide derivatives as beta2-adrenoreceptor agonists
AU2002359995A1 (en) DECAHYDRONAPHTHO(2,3-c)FURAN DERIVATIVES
AU2002340567A1 (en) 8beta -substituted-11beta -aryl-estra-1,3,5(10)-triene derivatives
AU2003255737A1 (en) Antimicrobial 2, 4-diamino-pteridine derivatives
AU2002329500A1 (en) New sulfonamide derivatives as d3-receptor agonists
AU2002342730A1 (en) Pyrane derivatives as both ace- and nep- inhibitors